国新健康
(000503)
| 流通市值：92.45亿 | | | 总市值：94.99亿 |
| 流通股本：9.55亿 | | | 总股本：9.81亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 200,175,797.05 | 137,393,382.51 | 47,915,544.2 | 330,126,718.06 |
| 营业收入 | 200,175,797.05 | 137,393,382.51 | 47,915,544.2 | 330,126,718.06 |
| 二、营业总成本 | 310,493,245.6 | 214,938,640.59 | 90,887,714.68 | 445,864,539.22 |
| 营业成本 | 193,333,505.34 | 141,271,985.72 | 56,278,290.3 | 248,139,370.7 |
| 税金及附加 | 1,270,673.72 | 716,279.28 | 207,498.17 | 1,620,650.98 |
| 销售费用 | 42,708,861.39 | 25,731,510.07 | 11,031,099.74 | 61,972,625.98 |
| 管理费用 | 71,392,383.75 | 46,665,327.62 | 22,052,798.58 | 128,429,895.76 |
| 研发费用 | - | 0 | 0 | 967,945.83 |
| 财务费用 | 1,787,821.4 | 553,537.9 | 1,318,027.89 | 4,734,049.97 |
| 其中:利息费用 | 5,715,954.47 | 3,836,425.01 | 1,792,860.34 | 5,117,337.35 |
| 其中:利息收入 | 4,092,215.61 | 3,353,270.01 | 500,069.83 | 628,224.57 |
| 加:公允价值变动收益 | - | - | 0 | 27,271,270.32 |
| 加:投资收益 | 72,827,431.33 | 1,218,785.01 | 1,382,398.95 | 12,493,403.64 |
| 资产处置收益 | 55,933.8 | 30,154.44 | - | 107,180.99 |
| 资产减值损失(新) | 2,852,277.95 | 2,905,608.65 | -856,379.33 | -4,631,299.54 |
| 信用减值损失(新) | -3,190,634.52 | -5,264,558.59 | 1,795,408.37 | -6,613,613.29 |
| 其他收益 | 521,231.53 | 481,881.25 | 438,435.93 | 4,437,275.1 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | -37,251,208.46 | -78,173,387.32 | -40,212,306.56 | -82,673,603.94 |
| 加:营业外收入 | 5,531,933.08 | 5,511,925.55 | 110,416.19 | 6,665,045.92 |
| 减:营业外支出 | 344,913.17 | 344,912.96 | 277,921.26 | 2,401,752.24 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | -32,064,188.55 | -73,006,374.73 | -40,379,811.63 | -78,410,310.26 |
| 减:所得税费用 | -26,402.34 | -26,402.34 | 425 | 1,909,127.76 |
| 六、净利润 | -32,037,786.21 | -72,979,972.39 | -40,380,236.63 | -80,319,438.02 |
| 持续经营净利润 | -32,037,786.21 | -72,979,972.39 | -40,380,236.63 | -80,319,438.02 |
| 归属于母公司股东的净利润 | -30,946,674.76 | -72,981,492.63 | -40,381,786.35 | -79,791,984.63 |
| 少数股东损益 | -1,091,111.45 | 1,520.24 | 1,549.72 | -527,453.39 |
| (一)基本每股收益 | -0.03 | -0.07 | -0.04 | -0.09 |
| (二)稀释每股收益 | -0.03 | -0.07 | -0.04 | -0.09 |
| 八、其他综合收益 | -145,922.56 | 86,978.58 | 24,529.14 | 7,084,483.19 |
| 归属于母公司股东的其他综合收益 | -145,922.56 | 86,978.58 | 24,529.14 | 7,084,483.19 |
| 九、综合收益总额 | -32,183,708.77 | -72,892,993.81 | -40,355,707.49 | -73,234,954.83 |
| 归属于母公司股东的综合收益总额 | -31,092,597.32 | -72,894,514.05 | -40,357,257.21 | -72,707,501.44 |
| 归属于少数股东的综合收益总额 | -1,091,111.45 | 1,520.24 | 1,549.72 | -527,453.39 |
| 公告日期 | 2024-10-26 | 2024-08-29 | 2024-04-27 | 2024-04-27 |
| 审计意见(境内) | | | | 标准无保留意见 |